Mumbai-based pharma manufacturer of finished dosages and APIs, exporting to 55+ countries.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 661 | 751 | 886 | 1.0k | 1.1k | 1.0k | 961 | 921 |
| Borrowings | 262 | 267 | 257 | 333 | 672 | 994 | 999 | 1.1k |
| Other Liabilities | 330 | 279 | 325 | 297 | 363 | 414 | 530 | 564 |
| Total Liabilities | 1.3k | 1.3k | 1.5k | 1.7k | 2.1k | 2.4k | 2.5k | 2.6k |
| AssetsFixed Assets | 590 | 570 | 555 | 678 | 954 | 997 | 1.1k | 1.3k |
| CWIP | 51 | 68 | 122 | 114 | 125 | 321 | 182 | 28 |
| Investments | 0 | 0 | 0 | 2 | 9 | 1 | 1 | 1 |
| Other Assets | 631 | 677 | 809 | 864 | 1.1k | 1.1k | 1.2k | 1.3k |
| Total Assets | 1.3k | 1.3k | 1.5k | 1.7k | 2.1k | 2.4k | 2.5k | 2.6k |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
INDOCO · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.